Genedata
Genedata AG is a Switzerland-based enterprise software company, founded 1997 and owned by Danaher since 2024, that provides a unified Biopharma Platform with embedded AI for biologics discovery, bioprocess development, and CMC workflows. Its modules serve the majority of top-100 global pharma plus biotechs, CROs, CDMOs, and agricultural biotech companies.
- Company typePrivate
- Founded1997
- HeadquartersBasel, Switzerland
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
What Genedata does
Genedata AG is a Switzerland-headquartered enterprise software company founded in 1997 that develops a unified Biopharma Platform combining a single data model with workflow automation and embedded AI to accelerate discovery, development, and manufacturing of biologics and other therapeutic modalities. The platform is delivered through a suite of integrated modules: Genedata Biologics for biotherapeutics discovery and protein engineering; Genedata Bioprocess for cell line development, upstream/downstream process development, and CMC; Genedata Expressionist for mass spectrometry and Multi-Attribute Method analysis; Genedata Screener for high-throughput assay data analysis (SPR, HT-Flow, HCS, patch clamp); Genedata Selector for NGS-based biosafety and CRISPR workflows; Genedata Profiler for precision medicine; Genedata Chromatics for chromatography; and Genedata Vico, an AI-native CMC platform built on Anthropic's Claude frontier model family.
The company sells quote-based enterprise licenses and SaaS subscriptions to a roster that includes the majority of top-100 global pharmaceutical companies (Pfizer, Novartis, Roche, AstraZeneca, Sanofi, GSK, Merck, J&J, AbbVie, Lilly, Bayer, Boehringer Ingelheim, Takeda, Daiichi-Sankyo, Novo Nordisk) plus biotechnology firms (Amgen, Genmab, Biogen, Gilead, MorphoSys, Immunocore, UCB), CROs/CDMOs (Charles River, Evotec, mAbxience, Syngene), and agricultural biotech (Rijk Zwaan, Ajinomoto). Distribution is primarily direct enterprise field sales with regional offices in Basel, Boston, London, Japan, and Singapore, augmented by technology partnerships with instrument vendors (Bruker, SCIEX, LECO, Sartorius) and co-development alliances with major pharma (AstraZeneca for SPR, Bayer for CLD, top-10 pharma for Vico).
Since August 2024, Genedata has operated as a subsidiary of Danaher Corporation, gaining access to cross-selling across Danaher's life sciences portfolio and the Danaher Business System. Revenue is generated through enterprise software licenses (on-premise perpetual), SaaS subscriptions (notably Genedata Bioprocess), and professional services including Scientific Success and GxP compliance support. Headcount is reported at 51-100 employees, and pricing is not publicly disclosed.
Genedata firmographics
Firmographics- Name
- Genedata
- Legal name
- Genedata AG
- Website
- https://genedata.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Genedata AG is a Switzerland-based enterprise software company, founded 1997 and owned by Danaher since 2024, that provides a unified Biopharma Platform with embedded AI for biologics discovery, bioprocess development, and CMC workflows. Its modules serve the majority of top-100 global pharma plus biotechs, CROs, CDMOs, and agricultural biotech companies.
- Ownership category
- akta.pro rank
Genedata industry classification
Industry- Product category
- Biopharmaceutical R&D Software
- NAICS
- Computer Systems Design and Related Services (54151), Scientific Research and Development Services (5417)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where Genedata is headquartered
LocationHeadquarters
- HQ city
- Basel
- HQ country
- Switzerland
- HQ region
- Europe
Offices5 records
Markets served
Genedata business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Enterprise Software Licenses (On-premise): Traditional perpetual license model for on-premises deployment of enterprise software platforms. Customers pay upfront license fees with annual maintenance and support contracts.
- SaaS Subscriptions: Software-as-a-service subscription model for cloud-hosted deployments. Genedata Bioprocess is specifically noted as a SaaS-based platform. Subscription model enables recurring revenue and regular software updates.
- Professional Services: Implementation, customization, training, and deployment support services. Includes Scientific Success services and GxP Services for regulatory compliance.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise software pricing based on deployment scope, user count, and modules selected |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
Genedata product offering
Product offeringCore offering
Genedata develops enterprise software platforms for biopharmaceutical R&D, combining a unified data model with workflow automation and embedded AI to support discovery, development, and manufacturing of biologics and other modalities. Its Genedata Biopharma Platform consists of integrated modules covering biotherapeutics discovery, bioprocess and CMC development, mass spectrometry analysis, assay screening, NGS workflows, precision medicine, and chromatography, sold via on-premises licenses, SaaS subscriptions, and professional services to top global pharmaceutical, biotech, CRO, CDMO, and agricultural biotech customers.
Product overview
Genedata offers a unified Biopharma Platform architecture consisting of multiple integrated product modules. The core platform combines a single, unified data model with workflow automation and embedded AI. Key modules include: Genedata Biologics for biotherapeutics discovery workflows; Genedata Bioprocess for CMC and bioprocess development; Genedata Expressionist for mass spectrometry data analysis; Genedata Screener for assay screening data analysis; Genedata Selector for NGS-based development and biosafety; Genedata Profiler for precision medicine; Genedata Chromatics for chromatography workflows; and Genedata Vico for AI-driven CMC. The platform supports all major therapeutic modalities including antibodies, bispecifics, ADCs, cell therapies, gene therapies, RNA therapies, vaccines, and small molecules. Genedata is a Danaher company headquartered in Basel, Switzerland, founded in 1997.
Differentiator
Problem solved
Functional benefit
Products and services
- Genedata Biopharma Platform
Quantifiable outcome
- Up to 80% of losses from failed batches can be recouped using Genedata Vico AI-native CMC platform
- +4 more outcomes
Companies that use Genedata
Customer profileNamed customers36 records
Segments6 records
Ideal customer profiles4 records
Genedata technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature8 records
Genedata partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered flagship, core and minor.
- Top 10 Pharmaceutical Companies (co-development)flagshipGenedata Vico AI-native CMC platform co-developed with top 10 pharmaceutical companies. This strategic collaboration ensures the platform addresses real-world CMC challenges and is validated by industry leaders before launch.
- mAbxiencecoremAbxience selected Genedata Bioprocess to implement automated, SaaS-based platform for bioprocess data management across its biopharmaceutical CDMO operations.
- BrukercoreIntegration of Genedata Screener with Bruker's biophysics automation platforms (SPR Pro8 Series, timsTOF MALDI PharmaPulse) for data management in high-throughput screening and AI-driven drug discovery workflows.
- ImmunocorecoreImmunocore adopted Genedata Biologics and Genedata Screener to scale up discovery of novel TCR therapeutics.
- Takara BiocoreTakara Bio integrated Genedata Expressionist for Genomic Profiling for multi-omics data processing across its regenerative medicine and cell therapy research.
- AGU (Augsburg, Germany)minorPartnership for bioprocess automation with German biotech company AGU to advance bioprocess development capabilities.
- MorphoSyscoreExpanded collaboration since 2009. Genedata Biologics serves as workflow backbone for MorphoSys antibody discovery programs including Ylanthia, Slonomics, and HuCAL libraries.
- DataHowminorPartnership to digitalize bioprocess development and manufacturing through DataHow's process analytics expertise combined with Genedata Bioprocess platform.
- IntelliCyt (Sartorius)coreAlliance integrating Genedata Screener software with IntelliCyt iQue Screener system for high-throughput flow cytometry screening. First highly scalable HT-Flow cytometry solution for drug discovery.
- Bayer Pharma AGcoreCollaboration to develop Cell Line Development (CLD) data platform for automation of mammalian cell line development processes for biopharmaceutical production.
- AstraZenecaflagshipCo-developed Genedata Screener for SPR (Surface Plasmon Resonance) data analysis platform. AstraZeneca led standardization and quality improvement of SPR screening workflows.
- AB SCIEX and LECO CorporationcoreTechnology partnership for metabolomics data analysis solution. Combines Genedata Expressionist MSX with AB SCIEX LC/MS and LECO GC/MS technologies to enable comprehensive processing and analysis of metabolomics experimental data.
- Tata Consultancy ServicesminorParticipated in leadership discussion on digital transformation in Indian pharma industry alongside Dr. Reddy's Laboratories, Sun Pharma, and Matrix Pharma.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Genedata competitors and assessment
Company assessmentDirect peers
- BIOVIA (Dassault Systèmes): BIOVIA is Dassault Systèmes' scientific informatics portfolio covering biologics discovery, bioprocess, and lab informatics. It is the broadest direct competitor to Genedata's enterprise platform across discovery-to-manufacturing workflows in biopharma R&D.
- Dotmatics (Siemens Digital Industries): Dotmatics provides a scientific informatics platform (LIMS, ELN, inventory, biology, chemistry) widely used by pharma and biotech. Acquired by Siemens in 2024, it competes head-on with Genedata across discovery biology and chemistry workflows.
- Benchling: Benchling is a cloud-native R&D platform with strong adoption in biologics, cell therapy, and gene therapy. It targets the same biopharma R&D buyers as Genedata, particularly biotechs, with a more modern UX and faster onboarding model.
- Revvity Signals (formerly PerkinElmer Informatics): Revvity Signals offers TIBCO Spotfire and the Signals scientific data platform used in pharma and biotech discovery and development. It competes with Genedata on analytics, multi-omics, and translational research informatics.
- Sapio Sciences: Sapio Sciences provides a unified lab informatics platform (LIMS, ELN, SDMS) used in biopharma discovery and development. It overlaps with Genedata on biologics and molecular biology workflow management.
- LabVantage Solutions: LabVantage is a LIMS provider with strong biopharma and biobanking deployments. It competes with Genedata's bioprocess and CMC workflows that overlap with regulated laboratory data management requirements.
- ACD/Labs (Advanced Chemistry Development): ACD/Labs specializes in analytical, chemistry, and chromatography data management used in pharma R&D and manufacturing. Its analytical and chromatography solutions overlap with Genedata Expressionist and Genedata Chromatics.
Emerging players
- TetraScience: TetraScience provides a scientific data cloud and AI-native data layer for life sciences R&D and manufacturing. It is an emerging challenger targeting the same AI-readiness and unified data model positioning that Genedata Vico now pursues.
- Scitara: Scitara offers a scientific data connectivity platform for lab instruments and informatics systems in pharma and biotech. It addresses the same instrument-integration and data-flow pain points that underpin Genedata's unified platform.
Others
- IDBS (Danaher): IDBS is a Danaher sister company offering scientific informatics for biologics and process development. It is now a portfolio peer under the same parent as Genedata; the two compete historically but increasingly face co-existence or integration risk.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Genedata social profiles
Digital presenceGenedata financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genedata leadership team
Management profileNumber of profiles
Profiles1 record
Genedata funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genedata M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genedata
What does Genedata do?
Genedata develops enterprise software platforms for biopharmaceutical R&D, combining a unified data model with workflow automation and embedded AI to support discovery, development, and manufacturing of biologics and other modalities. Its Genedata Biopharma Platform consists of integrated modules covering biotherapeutics discovery, bioprocess and CMC development, mass spectrometry analysis, assay screening, NGS workflows, precision medicine, and chromatography, sold via on-premises licenses, SaaS subscriptions, and professional services to top global pharmaceutical, biotech, CRO, CDMO, and agricultural biotech customers.
Is Genedata a public or private company?
Genedata is a private company. It is classified as corporate owned and is currently operating.
When was Genedata founded?
Genedata was founded in 1997. It employs 251 to 500 people.
Where is Genedata based?
Genedata is headquartered in Basel, Switzerland, in the Europe region.
How does Genedata make money?
Three revenue lines are on record. Enterprise Software Licenses (On-premise) is the primary driver. The others are saaS Subscriptions and professional Services.
Who are Genedata's main competitors?
Direct peers on record are BIOVIA (Dassault Systèmes), Dotmatics (Siemens Digital Industries), Benchling, Revvity Signals (formerly PerkinElmer Informatics), Sapio Sciences, LabVantage Solutions and ACD/Labs (Advanced Chemistry Development). Emerging players are TetraScience and Scitara. IDBS (Danaher) is listed as an others.
Does Genedata have an API?
No public API is recorded for Genedata.
What industry is Genedata in?
Genedata's product category is Biopharmaceutical R&D Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 54151 and its SIC code is 7372.